Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.
Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check51 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
- Check58 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
- Check71 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content or details of the webpage.SummaryDifference0.3%
- Check77 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision or update to the content of the webpage.SummaryDifference0.3%
Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.